Literature DB >> 6038326

Ehlers-Danlos syndrome.

R M Bannerman, C J Graf, J F Upson.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 6038326      PMCID： PMC1842887          DOI： 10.1136/bmj.3.5564.558-b

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  EHLERS-DANLOS SYNDROME ASSOCIATED WITH MULTIPLE INTRACRANIAL ANEURYSMS.

Authors:  M K RUBINSTEIN; N H COHEN
Journal:  Neurology       Date:  1964-02       Impact factor: 9.910

2.  Spontaneous carotid-cavernous fistula. Ehlers-Danlos syndrome and related conditions.

Authors:  C J Graf
Journal:  Arch Neurol       Date:  1965-12
  2 in total
  7 in total

1.  Spontaneous rupture of the abdominal aorta.

Authors:  T G Williams
Journal:  Postgrad Med J       Date:  1977-04       Impact factor: 2.401

2.  Gastrointestinal complications of the Ehlers-Danlos syndrome.

Authors:  P H Beighton; J L Murdoch; T Votteler
Journal:  Gut       Date:  1969-12       Impact factor: 23.059

3.  Lethal complications of the Ehlers-Danlos syndrome.

Authors:  P Beighton
Journal:  Br Med J       Date:  1968-09-14

4.  Serious ophthalmological complications in the Ehlers-Danlos syndrome.

Authors:  P Beighton
Journal:  Br J Ophthalmol       Date:  1970-04       Impact factor: 4.638

5.  Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients.

Authors:  P Beighton; A Price; J Lord; E Dickson
Journal:  Ann Rheum Dis       Date:  1969-05       Impact factor: 19.103

6.  Fatal splenic rupture in Ehlers-Danlos syndrome.

Authors:  S C Harris; D N Slater; C A Austin
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

Review 7.  Pathophysiology of carotid-cavernous fistulas in vascular Ehlers-Danlos syndrome: a retrospective cohort and comprehensive review.

Authors:  Salma Adham; Denis Trystram; Juliette Albuisson; Valérie Domigo; Anne Legrand; Xavier Jeunemaitre; Michael Frank
Journal:  Orphanet J Rare Dis       Date:  2018-06-25       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.